osteoarthritis
Pain · 2005–2014
13decisions
5medicines
1carried consumer input
0individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| paracetamol Relief of persistent pain associated with osteoarthritis. | Nov 2014 | Not recommended | input received |
| naproxen and esomeprazole Symptomatic treatment of osteoarthritis, rheumatoid arthritis or ankylosing spondylitis in patients who require an NSAID and are at increased risk of… | Jul 2013 | Not recommended | no section in document |
| Naproxen and esomeprazole Symptomatic treatment of osteoarthritis, rheumatoid arthritis or ankylosing spondylitis in a patient who requires a non-steroidal anti-inflammatory drug… | Mar 2012 | Not recommended | unclear |
| naproxen and esomeprazole Symptomatic treatment of osteoarthritis, rheumatoid arthritis or ankylosing spondylitis in patients who require an NSAID and are at high risk of… | Mar 2012 | Not recommended | unclear |
| naproxen and esomeprazole Symptomatic treatment of osteoarthritis, rheumatoid arthritis or ankylosing spondylitis in patients who require an NSAID and are at high risk of… | Nov 2012 | Not recommended | unclear |
| etoricoxib Symptomatic treatment of the signs and symptoms of osteoarthritis | Jul 2008 | Not recommended | no section in document |
| etoricoxib Symptomatic treatment of osteoarthritis. | Jul 2008 | Not recommended | no section in document |
| etoricoxib Symptomatic treatment of the signs and symptoms of osteoarthritis (OA) | Jul 2007 | Recommended | no section in document |
| etoricoxib Symptomatic treatment of osteoarthritis. | Jul 2007 | Recommended | no section in document |
| Glucosamine Hydrochloride symptomatic treatment of osteoarthritis | Jul 2006 | Not recommended | no section in document |
| glucosamine hydrochloride Symptomatic treatment of osteoarthritis. | Jul 2006 | Not recommended | no section in document |
| lumiracoxib Symptomatic treatment of osteoarthritis. | Nov 2005 | Recommended with restriction | no section in document |
| lumiracoxib Symptomatic treatment of osteoarthritis. | Nov 2005 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.